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Abstract 
Background: Orangutans are an endangered species whose natural habitats are restricted to the Southeast Asian 
islands of Borneo and Sumatra. Along with the African great apes, orangutans are among the closest living relatives to 
humans. For potential species conservation and functional genomics studies, we derived induced pluripotent stem 
cells (iPSCs) from cryopreserved somatic cells obtained from captive orangutans.
Results: Primary skin fibroblasts from two Sumatran orangutans were transduced with retroviral vectors express‑
ing the human OCT4, SOX2, KLF4, and c‑MYC factors. Candidate orangutan iPSCs were characterized by global gene 
expression and DNA copy number analysis. All were consistent with pluripotency and provided no evidence of 
large genomic insertions or deletions. In addition, orangutan iPSCs were capable of producing cells derived from all 
three germ layers in vitro through embryoid body differentiation assays and in vivo through teratoma formation in 
immune‑compromised mice.
Conclusions: We demonstrate that orangutan skin fibroblasts are capable of being reprogrammed into iPSCs with 
hallmark molecular signatures and differentiation potential. We suggest that reprogramming orangutan somatic 
cells in genome resource banks could provide new opportunities for advancing assisted reproductive technologies 
relevant for species conservation efforts. Furthermore, orangutan iPSCs could have applications for investigating the 
phenotypic relevance of genomic changes that occurred in the human, African great ape, and/or orangutan lineages. 
This provides opportunities for orangutan cell culture models that would otherwise be impossible to develop from 
living donors due to the invasive nature of the procedures required for obtaining primary cells.
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Background
Orangutans are southeast Asian great apes that last 
shared a common ancestor with humans and the African 
great apes (chimpanzees, bonobos, and gorillas) 12–16 
million year ago [1]. The native geographical distribution 
of the two orangutan species is currently restricted to the 
South-East Asian islands of Borneo (Pongo pygmaeus) 
and Sumatra (Pongo abelii) [2]. Their speciation time is 
estimated to be approximately 300,000–400,000  years 
ago, with evidence of continued low levels of gene flow 
afterwards [1, 3]. Both orangutan species are classified as 
endangered [4, 5] with an estimated 6600 Sumatran and 
54,000 Bornean individuals alive in 2004 [6]. In general, 
orangutan census techniques are subject to interpreta-
tion since they are most commonly based on the density 
of orangutan nests due to the fact that direct counts of 
animals are hindered by low encounter rates [7]. Nev-
ertheless, the indisputable rapid decline in Sumatran 
and Bornean orangutan populations (suggested aver-
age annual losses of 230–400 Sumatran and 2050–4850 
Bornean orangutans over the last 25  years) has height-
ened awareness that rapid action is needed for conversa-
tion efforts to be effective [5, 8–10].
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The ability to reprogram somatic cells obtained from 
living or recently deceased donors into induced pluripo-
tent stem cells (iPSCs) provides exciting new opportuni-
ties for conversation biology [11]. While reprogramming 
technologies are constantly evolving, traditionally this 
has been accomplished through the transient expression 
of a group of transcription factors (OCT4, SOX2, KLF4, 
and c-MYC), also called Yamanaka reprogramming fac-
tors, in cultured somatic cells. iPSCs can be expanded 
indefinitely and differentiated into cells from all three 
germ layers. This is highlighted by ongoing efforts to 
develop methods to differentiate iPSCs from endan-
gered species into germ cells for the in vitro production 
of embryos that can be implanted into surrogate females 
of a related existing species [12]. This would further 
enhance the value of cryopreserved cells banks, such as 
the Frozen Zoo© at the Zoological Society of San Diego 
[13, 14]. The initial reports of iPSCs derived from endan-
gered species involved the silver-maned drill monkey and 
northern white rhinoceros [15] followed by the prairie 
vole [16] and snow leopard [17]. Most recently, iPSCs 
have been reported for small numbers of chimpanzees, 
bonobos, and gorillas using traditional Yamanaka repro-
gramming factors and retroviral vectors that integrated 
into the genome [18, 19]. iPSCs has also been derived 
from two chimpanzees using reprogramming methods 
that do not involve the genomic integration of transgenes 
[20]. Despite these reports involving African great apes 
as well as non-endangered primates used in biomedical 
research [21], the derivation of iPSCs from orangutans 
has not been reported to date.
In addition to the aforementioned conservation efforts, 
orangutans have also been studied because of their com-
plex behaviors [22] and their phylogenetic relationships 
with humans and the African great apes [23]. While the 
social behaviors [24–26] and adept tool use [26–32] of 
orangutans have been extensively studied, it remains a 
challenge to catalog the underlying genetic underpin-
nings for the cognitive abilities and other specializations 
in the orangutan lineage. Genomic analyses have indi-
cated positive selection in the orangutan lineage of genes 
that play critical roles in pathways pertaining to visual 
perception and glycolipid metabolism relevant to neu-
rological functions [1]. Nevertheless, it is difficult to test 
hypotheses regarding the functional relevance of these 
genomic signatures of selection given the limited avail-
ability of appropriately preserved orangutan tissues and 
cultured cells outside of primary skin fibroblasts [33] and 
transformed lymphoblasts [34]. A recent investigation of 
enhancer divergence and cis-regulatory evolution in the 
human and chimp neural crest using iPSC-derived cell 
culture models highlights the value these models can 
have in addressing fundamental questions in molecular 
evolution [35]. Furthermore, more complex organoid 
models, such as ‘mini-brains’, that can be developed from 
iPSCs [36] would open new opportunities to engage in 
comparative neuroscience studies.
Here, we report the generation of orangutan iPSCs as 
a novel resource for conservation biology and investigat-
ing the functional relevance of genetic changes that could 
have contributed to phenotypic specializations in great 
apes. Gene expression information obtained from these 
orangutan iPSCs as part of their characterization could 
provide information relevant to molecular changes that 
have occurred after the split of the human and orangutan 
lineages. Furthermore, these resources provide an initial 
step required for the development of in vitro model sys-
tems to investigate potential differences in the produc-
tion and activities of specialized cell types in humans and 
the great apes.
Results and discussion
Derivation of candidate iPSCs from primary orangutan skin 
fibroblasts
Primary skin fibroblast cultures previously derived from 
punch biopsies of the upper limbs of two Sumatran oran-
gutans (KB10973, 29  year old male; KB10460, 43  year 
old female) [33] were obtained from the Zoological 
Society of San Diego. They were transduced with ret-
roviruses designed to express the human OCT4, SOX2, 
KLF4 and c-MYC genes, as previously described [37, 
38] (“Methods” Section). We observed iPSC-like colo-
nies by 2 weeks and clonally expanded TRA-1–60 posi-
tive colonies by 3  weeks, consistent with prior reports 
of reprogramming skin fibroblasts from healthy human 
donors [37, 39]. Candidate iPSC colonies KB10973-1 
and KB10460-1 showed the expected morphological fea-
tures and expressed protein biomarkers of pluripotency 
(Fig. 1). No differences were observed in orangutan iPSC 
with respect the colony morphology, passage characteris-
tics, or molecular characteristics relative to other human 
iPSCs that were produced in our laboratory at approxi-
mately the same time [37, 38].
In vitro differentiation of orangutan iPSCs and teratoma 
assays
Orangutan iPSCs were capable of forming embryoid 
bodies which were capable of producing cells derived 
from all three germ layers, as assessed by in vitro differ-
entiation assays (“Methods” Section) (Fig.  1). Further-
more, both orangutan iPSCs tested formed teratomas 
when injected into immune-deficient mice (“Methods” 
Section). Figure  2 depicts the histology of one of these 
teratomas, which demonstrated the presence of tis-
sues representative of all three germ layers. The results 
of in  vitro and in  vivo differentiation assays conducted 
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Fig. 1 Images of orangutan iPSCs and derivatives. Data pertaining to KB10973 iPSC colony 1 (Panels a–k) and KB10460 iPSC colony 1 (panels 
l–v) are provided, as described in “Methods” Section. Light microscope images of iPSCs are shown in panels (a, l). Alkaline phosphatase staining 
is depicted in panels (b, m). Images of iPSCs immunostained for TRA‑1‑60 (panels c, n), TRA‑1‑81 (panels d, o), SSEA4 (panels e, p), OCT4 (panels f, 
q), SOX2 (panels g, r), and NANOG (panels h, s) are shown. DAPI nuclear counterstaining is not shown for the purpose of image clarity. Panels t–v 
provide the results of in vitro differentiation assays conducted on KB10973 iPSC colony 1 (panels i–k) and KB10460 iPSC colony 1. Cell populations 
derived from each of the three germ layers were detected by immunostaining for AFP (endoderm; panels i, t), SMA (mesoderm; panels j, u), and 
beta‑III‑tubulin (ectoderm; panels k, v). Nuclei were counterstained with DAPI (blue) in panels t–v
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on orangutan iPSCs were indistinguishable from those 
of human iPSCs produced in our laboratory at approxi-
mately the same time [37, 38].
Gene expression profiles of orangutan donor cells
We validated the robust expression of previously 
reported iPSC signature genes [39] in multiple candi-
date orangutan donor-derived iPSC colonies and skin 
fibroblasts based on global gene expression profiling 
data of over 18,000 transcripts conducted on human 
GeneChip microarrays (Additional file 1). Unsupervised 
hierarchical clustering analysis based on the expression 
of the most variable transcripts [i.e. coefficient of vari-
ation (CV) >0.25 across all samples)] (Fig. 3a) or prese-
lected pluripotency biomarkers produced two distinct 
clusters consisting of skin fibroblasts and the iPSCs 
(Fig.  3b). As expected, the pluripotency biomarkers 
consistency showed higher expression in the iPSCs rela-
tive to the fibroblasts (Fig. 3b). All iPSC gene expression 
profiles showed similar expression signatures as demon-
strated by the dendrograms shown in Fig.  3a, b. Since 
all samples were derived from orangutans, our report 
of differentially expressed genes between fibroblasts 
and iPSCs are valid. Nevertheless, any genes with low 
expression in fibroblasts and iPSCs samples could be 
influenced by mismatches between the orangutan tran-
script and human probes [40]. We provide alignments 
of human probe sequences corresponding to these 
pluripotency genes and orangutan genomic sequences 
in Additional file 2. Overall, the orangutan gene profil-
ing results were consistent with that of human iPSCs 
produced in our laboratory at approximately the same 
time [37, 38].
Genotypes and DNA copy number profiles of iPSCs
As expected, SNP genotypes in iPSCs and correspond-
ing donor fibroblasts were concordant by analysis on 
CytoSNP-12 BeadArrays, consisting of 50 mer oligonu-
cleotide probes designed to interrogate human genomes 
(“Methods” Section). Based on comparing hybridization 
signals from fibroblast and iPSC genomic DNA (gDNA) 
samples obtained from the same donor, we did not detect 
large copy number changes (CNCs) in the iPSCs analyzed 
(Additional file 3). Since all comparisons involve orangu-
tan gDNAs that share approximately 0.974 nucleotide 
identity in unique gap free sequences with the human 
gDNAs [1], we minimize the chance that mismatches 
between orangutan gDNAs and the BeadArray probes 
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Fig. 2 iPSC teratoma assay. Histological analysis of a teratoma derived from KB10973 iPSC colony 1 is provided. Cell populations representative of 
all three germ layers are present as indicated. Arrows correspond to annotations provided under each panel. Scale bars on the top two rows and 
bottom row of tissue sections are 200 µm and 50 µM, respectively
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will result in the spurious calling of genomic deletions in 
the orangutan iPSCs.
Conclusions
We have demonstrated that cryopreserved skin fibro-
blasts from orangutans can be reprogrammed into iPSCs 
using the Yamanaka factors. Their ability to produce cells 
from all three germ layers in  vitro and in  vivo provides 
evidence of their pluripotency (Figs.  1, 2). Since iPSC 
colonies could be derived from these fibroblast cultures 
using the traditional retroviral methods, they should also 
have utility in evaluating non-retroviral reprogramming 
methods that do not alter the genome [41].
Orangutan iPSCs have potential applications for con-
servation biology in the present time as well as in the 
future. In terms of immediate relevance, orangutan iPSCs 
can be used to evaluate protocols for deriving germ cells 
from iPSCs [42–46]. Even if functional male and female 
gametes could be derived from genetically unaltered 
iPSCs in the future, numerous challenges for their appli-
cations in assisted reproductive technologies will remain 
[11, 12]. Furthermore, these technologies do not address 
vital issues regarding the preservation of the natural hab-
itats of endangered species.
Transcriptome analyses of cultured human and great 
ape fibroblasts [47] and lymphoblastoid cell lines [48–50] 
have been used generate specific hypotheses regarding 
evolutionary selection in various primate lineages. In 
the former case [47], follow up studies were conducted 
on blood specimens that can be ethically obtained from 
living great apes and other non-human primates [33, 51, 
52]. Although landmark studies have been performed on 
autopsy materials from great apes [53–57], appropriate 
biological specimens from deceased individuals are often 
difficult to obtain from a significant number of indi-
viduals. Likewise, ethical and sample acquisition issues 
strongly affect research into adaptations that affect devel-
opmental processes in each of these lineages.
Cross-species comparisons of the development and 
functions of central nervous system (CNS) cell line-
ages are of among those of greatest interest for human 
evolutionary biology [58]. iPSCs from humans, orangu-
tans, and other great apes provide a gateway to address 
focused hypotheses regarding the timing of neurological 
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Fig. 3 Gene expression profiles of orangutan fibroblasts and candidate iPSCs. Dendrograms depicting unsupervised hierarchical clustering analysis 
of gene expression data from skin fibroblasts and iPSCs derived from orangutan donors. Donor ID is provided along with colony number in the 
case of iPSCs. All analyses were conducted using average linkage and Euclidean distance. a Clustering based on log2‑transformed gene expression 
scores from 546 probe sets with coefficient of variation (CV) greater than 0.25 and conducted using average linkage and Euclidean distance. b Clus‑
tering based on log2‑transformed gene expression scores corresponding to 26 pluripotency‑related genes that are differentially expressed between 
fibroblasts and iPSC (>1.5 fold change, FDR < 0.05). Color bars represent log‑2 transformed gene expression values for each panel
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adaptations that have occurred within and among these 
species [58]. A recent application of iPSC and genomic 
technologies to investigate enhancer divergence and 
cis-regulatory evolution in the human and chimp-
derived cranial neural crest cells provides a model for 
future investigations in CNS cell types from orangutans, 
humans, and other great apes [35]. The mapping of fixed 
genetic changes across species that affect gene regulatory 
networks in a cell or tissue-specific manner would have 
enormous value for deciphering the molecular basis for 
phenotypic specializations in different ape lineages. As 
noted, iPSCs can also provide in vitro models of species-
specific developmental processes that are not otherwise 
accessible due to numerous ethical and practical reasons 
[35]. Furthermore, more complex organoid models, such 
as ‘mini-brains’, that can be developed from iPSCs [36] 
would open new opportunities to engage in comparative 
neuroscience studies.
While purified cell types are useful for investigating cell 
autonomous mechanisms, recent technological innova-
tions have allowed three-dimensional organoid models of 
the CNS [59] and other systems [60] to be derived from 
iPSCs in order to investigate non-cell autonomous mech-
anisms of biomedical relevance. These approaches could 
also be used to address questions relevant to human and 
great ape evolution. Finally, we note possible applica-
tions of genome editing technologies to investigate the 
functional relevance of genomic regions under selection 
within and among these primate lineages by introducing 
specific genetic changes in human and great ape iPSC-
derived cell types [61].
Methods
Cell culture
Previously established primary orangutan skin fibroblast 
cultures were obtained from the Zoological Society of San 
Diego (ZSSD) [33]. Cultured skin fibroblasts were main-
tained in fibroblast growth media containing Dulbecco’s 
modified eagle medium (DMEM) containing 10  % fetal 
bovine serum (FBS), 2 mM l-glutamine, 100 µM nones-
sential amino acids and 0.5 % penicillin and streptomycin 
(Invitrogen). 293T packaging cells were maintained in the 
same media except with 10 % FBS. iPSCs were generated 
and maintained in human iPSC (hiPSC) growth medium 
containing DMEM/F12 containing 20 % KOSR (vol/vol) 
(Invitrogen), 10 ng/ml bFGF, 1 mM l-glutamine, 100 µM 
nonessential amino acids, 100 µM β-mercaptoethanol, 50 
U/mL penicillin and 50 mg/mL streptomycin.
Cellular reprogramming
Cellular reprogramming was conducted using the 
Yamanaka factors as previously described [37]. Retro-
viral pMX vectors for human OCT-3/4, SOX2, KLF4 
and c-MYC were obtained from Addgene (https://www.
addgene.org/). Briefly, GP2-293 packaging cells (Clon-
tech) were plated at 2 × 106 cells per 100-mm dish and 
incubated overnight. The cells were transfected with 5 µg 
of pMX vectors and 5 µg of pVSV-G vectors in the pres-
ence of Lipofectamine Transfection Reagent (Invitrogen) 
and the media was replaced the next day. Virus contain-
ing supernatant was collected on days 2 and 3 post-trans-
fection and filtered through a 0.4 micron pore cellulose 
acetate filter (Corning).
Prior to transduction, primary orangutan cultures were 
plated at 8 × 105 cells per well of a 6-well plate and incu-
bated overnight. The cells were transduced with equal 
amounts of the four retroviruses in the presence of 5 ng/
ml protamine sulfate. The following day the virus con-
taining media was replaced with Fibroblast Growth (FG) 
medium. After another round of transduction, cells were 
trypsinized on day 6 and plated on a murine embryonic 
fibroblast (MEF) feeder layer at 2 × 105 cells per well of 
a 6-well plate. The next day, the medium was replaced 
with hiPSC growth medium containing 1  mM valproic 
acid and 10 ng/mL βFGF. After daily media changing for 
1  week, hiPSC culture medium conditioned with mito-
mycin C (Sigma-Aldrich) inactivated mouse embryonic 
fibroblasts (iMEFs) was used to support cell growth. 
Approximately 21  days after transduction, colonies 
exhibiting iPSC characteristics were picked mechanically 
and plated on iMEFs for expansion.
Immunostaining
Cells were first fixed with 4  % paraformaldehyde, per-
meabilized with 1  % triton, and incubated with the pri-
mary antibody overnight at 4  °C. After washing three 
times with PBS, the cells were incubated with the sec-
ondary antibodies for 1 h at room temperature. The fol-
lowing primary antibodies were used: TRA-1-81 (mouse 
monoclonal against human, 1:100 dilution, EMD Mil-
lipore, Catalog #MAB4381), TRA-1-60 (mouse mono-
clonal against human, 1:100 dilution, EMD Millipore, 
Catalog #MAB4360), OCT4 (goat polyclonal against 
human, 1:100 dilution, R&D Systems, Catalog #AF1759), 
NANOG (goat polyclonal against human, 1:50 dilution, 
R&D systems, Catalog #1997), SOX2 (goat polyclonal 
against mouse, rat and human, 1:100 dilution, Santa Cruz 
Biotechnology, Catalog #sc17320), SSEA4 (mouse mon-
oclonal against human, 1:100, Developmental Studies 
Hybridoma Bank, Catalog #MC-813-70), α-fetoprotein 
(AFP) (mouse monoclonal against human, 1:250 dilution, 
Sigma, Catalog #A8452), βIII-Tubulin (rabbit monoclo-
nal against rat, 1:100 dilution, Covance Catalog #MRB-
435P) and alpha smooth muscle actin (αSMA) (1:500 
dilution, Abcam, Catalog #ab5694). Secondary antibod-
ies used were rhodamine-labeled donkey anti-mouse 
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IgG (1:100 dilution, Santa Cruz Biotechnology, Catalog 
#sc-2300), FITC-labeled donkey anti-rabbit IgG (1:100 
dilution, Jackson ImmunoResearch, Catalog #711-095-
152), FITC-labeled donkey anti-goat IgG (1:100 dilution, 
Jackson ImmunoResearch, Catalog #705-095-003) and 
Alexa Fluor 488 donkey anti-mouse IgG (1:500 dilution, 
ThermoFisher Scientific, Catalog #R37114). The Alkaline 
Phosphatase Detection Kit (Sigma-Aldrich) was used 
according to the manufacturer’s protocol.
Genotyping and copy number analysis
Human CytoSNP-12 Infinium HD BeadChips (Illumina) 
that interrogate the genotypes of approximately 300,000 
human single nucleotide polymorphisms (SNPs) were 
used to evaluate copy number in total genomic DNA 
from orangutan fibroblasts and iPSCs. Data filtering was 
performed using GenomeStudio (Illumina). Copy num-
ber analysis was performed using CNVPartition version 
2.4.4, as previously described [62].
Gene expression profiling
Biotin-labeled cRNA targets obtained from total RNA 
samples (Affymetrix GeneChip IVT Labeling Kit) were 
processed and analyzed on Affymetrix Human Genome 
133A 2.0 GeneChips, as previously described [47]. 
All data normalization and analysis of differentially 
expressed genes (DEGSs) were conducted using WebAr-
ray software [63, 64]. We applied the RMA algorithm to 
generate log2-transformed gene expression values and 
used linear model statistical analysis (limma) to identify 
DEGSs with false discovery rates (FDRs), based on the 
spacings LOESS histogram (SPLOSH) method (Addi-
tional file  1B). We used CIMminer software (http://dis-
cover.nci.nih.gov/cimminer/home.do) for hierarchical 
clustering analysis [65].
In vitro differentiation and teratoma assays
iPSCs were detached from culture dishes with collagenase 
IV, maintained in suspension to induce embryoid body 
formation, and subjected to an in  vitro differentiation 
procedure as described [37]. For teratoma analysis, iPSCs 
from a confluent 10 cm2 plate were harvested and subcu-
taneously injected to the dorsal flanks of immunodeficient 
(SCID) mice (Jackson Laboratory). Teratomas were fixed 
in 10 % formalin, sectioned, stained with hematoxylin and 
eosin, and subject to histological analysis as described 
[37]. All mice used in this study were maintained in 
accordance with the Guide for the Care and Use of Ani-
mals (United States Department of Health and Human 
Services, Public Health Service, Bethesda, MD, 2012).
Availability of supporting data
Gene expression scores and .cel files supporting the 
results of this article are available in the National Center 
for Biotechnology Information (NCBI) Gene Expression 




iPSC: induced pluripotent stem cell; FBS: fetal bovine serum; CNC: copy 
number change.
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Additional file 1. Log‑transformed gene expression scores from 
orangutan fibroblasts and iPSCs. A complete list of log‑transformed gene 
expression scores from orangutan fibroblasts and iPSCs is provided along 
with their percentile rank within a given samples. Differentially expressed 
genes (1.5‑fold change FDR<0.05) are also provided.
Additional file 2. Orangutan sequences and probe tilings present in 
the human GeneChip microarrays that pertain to pluripotency genes. 
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human GeneChip arrays pertaining to pluripotency genes listed in refer‑
ence [39] are provided.
Additional file 3. Copy number variation analysis for orangutan iPSCs. 
Log base 2 of the ratio of subject (iPSC) and reference (fibroblast) R 
values for probes in the CNV BeadArray are provided for KB10973 iPSC 
colony 1 and KB10460 iPSC colony 1. All data is mapped onto the human 
karyotype.
Page 8 of 9Ramaswamy et al. BMC Res Notes  (2015) 8:577 
References
 1. Locke DP, Hillier LW, Warren WC, Worley KC, Nazareth LV, Muzny DM, Yang 
SP, Wang Z, Chinwalla AT, Minx P, et al. Comparative and demographic 
analysis of orang‑utan genomes. Nature. 2010;469:529–33.
 2. Nater A, Greminger MP, Arora N, van Schaik CP, Goossens B, Singleton I, 
Verschoor EJ, Warren KS, Krutzen M. Reconstructing the demographic his‑
tory of orang‑utans using Approximate Bayesian Computation. Mol Ecol. 
2015;24:310–27.
 3. Mailund T, Dutheil JY, Hobolth A, Lunter G, Schierup MH. Estimating 
divergence time and ancestral effective population size of Bornean and 
Sumatran orangutan subspecies using a coalescent hidden Markov 
model. PLoS Genet. 2011;7:e1001319.
 4. Meijaard E, Wich S. Putting orang‑utan population trends into perspec‑
tive. Curr Biol. 2007;17:R540.
 5. Meijaard E, Wich S, Ancrenaz M, Marshall AJ. Not by science alone: why 
orangutan conservationists must think outside the box. Ann N Y Acad Sci. 
2012;1249:29–44.
 6. Wich SA, Meijaard E, Marshall AJ, Husson S, Ancrenaz M, Lacy RC, van 
Schaik CP, Sugardjito J, Simorangkir T, Traylor‑Holzer K, et al. Distribution 
and conservation status of the orang‑utan (Pongo spp.) on Borneo and 
Sumatra: how many remain? Oryx. 2008;42:329–39.
 7. Mathewson PD, Spehar SN, Meijaard E, Nardiyono, Purnomo, Sasmirul A, 
Sudiyanto, Oman, Sulhnudin, Jasary et al. Evaluating orangutan census 
techniques using nest decay rates: implications for population estimates. 
Ecol Appl 2008; 18:208–221.
 8. Davis JT, Mengersen K, Abram NK, Ancrenaz M, Wells JA, Meijaard E. 
It’s not just conflict that motivates killing of orangutans. PLoS One. 
2013;8:e75373.
 9. Hockings KJ, McLennan MR, Carvalho S, Ancrenaz M, Bobe R, Byrne RW, 
Dunbar RI, Matsuzawa T, McGrew WC, Williamson EA, et al. Apes in the 
Anthropocene: flexibility and survival. Trends Ecol Evol. 2015;30:215–22.
 10. Spehar SN, Loken B, Rayadin Y, Royle JA. Comparing spatial capture–
recapture modeling and nest count methods to estimate orangutan 
densities in the Wehea Forest, East Kalimantan, Indonesia. Biol Conserv. 
2015;191:185–93.
 11. Mastromonaco GF, Gonzalez‑Grajales LA, Filice M, Comizzoli P. Somatic 
cells, stem cells, and induced pluripotent stem cells: how do they now 
contribute to conservation? Adv Exp Med Biol. 2014;753:385–427.
 12. Selvaraj V, Wildt DE, Pukazhenthi BS. Induced pluripotent stem cells for 
conserving endangered species? Nat Methods. 2011;8:805–7.
 13. Benirschke K. The frozen zoo concept. Zoo Biol. 1984;3:325–8.
 14. Ryder OA, McLaren A, Brenner S, Zhang YP, Benirschke K. DNA banks for 
endangered animal species. Science. 2000;288:275–7.
 15. Ben‑Nun IF, Montague SC, Houck ML, Tran HT, Garitaonandia I, Leonardo 
TR, Wang YC, Charter SJ, Laurent LC, Ryder OA, Loring JF. Induced 
pluripotent stem cells from highly endangered species. Nat Methods. 
2011;8:829–31.
 16. Manoli DS, Subramanyam D, Carey C, Sudin E, Van Westerhuyzen JA, Bales 
KL, Blelloch R, Shah NM. Generation of induced pluripotent stem cells 
from the prairie vole. PLoS One. 2012;7:e38119.
 17. Verma R, Holland MK, Temple‑Smith P, Verma PJ. Inducing pluripotency 
in somatic cells from the snow leopard (Panthera uncia), an endangered 
felid. Theriogenology. 2012;77:220–8.
 18. Marchetto MC, Narvaiza I, Denli AM, Benner C, Lazzarini TA, Nathanson 
JL, Paquola AC, Desai KN, Herai RH, Weitzman MD, et al. Differential 
L1 regulation in pluripotent stem cells of humans and apes. Nature. 
2013;503:525–9.
 19. Wunderlich S, Kircher M, Vieth B, Haase A, Merkert S, Beier J, Gohring G, 
Glage S, Schambach A, Curnow EC, et al. Primate iPS cells as tools for 
evolutionary analyses. Stem Cell Res. 2014;12:622–9.
 20. Fujie Y, Fusaki N, Katayama T, Hamasaki M, Soejima Y, Soga M, Ban H, 
Hasegawa M, Yamashita S, Kimura S, et al. New type of Sendai virus vector 
provides transgene‑free iPS cells derived from chimpanzee blood. PLoS 
One. 2014;9:e113052.
 21. Wu Y, Mishra A, Qiu Z, Farnsworth S, Tardif SD, Hornsby PJ. Nonhuman 
primate induced pluripotent stem cells in regenerative medicine. Stem 
Cells Int. 2012;2012:767195.
 22. Wich SA. Orangutans: geographic variation in behavioral ecology and 
conservation. Oxford: Oxford University Press; 2009.
 23. Hacia JG. Genome of the apes. Trends Genet. 2001;17:637–45.
 24. Krutzen M, Willems EP, van Schaik CP. Culture and geographic variation in 
orangutan behavior. Curr Biol. 2011;21:1808–12.
 25. Bourjade M, Call J, Pele M, Maumy M, Dufour V. Bonobos and orangutans, 
but not chimpanzees, flexibly plan for the future in a token‑exchange 
task. Anim Cognit. 2014;17:1329–40.
 26. Fox EA, van Schaik CP, Sitompul A, Wright DN. Intra‑and interpopulational 
differences in orangutan (Pongo pygmaeus) activity and diet: implica‑
tions for the invention of tool use. Am J Phys Anthropol. 2004;125:162–74.
 27. Herrmann E, Wobber V, Call J. Great apes’ (Pan troglodytes, Pan paniscus, 
Gorilla gorilla, Pongo pygmaeus) understanding of tool functional prop‑
erties after limited experience. J Comp Psychol. 2008;122:220–30.
 28. Hardus ME, Lameira AR, Van Schaik CP, Wich SA. Tool use in wild orang‑
utans modifies sound production: a functionally deceptive innovation? 
Proc Biol Sci. 2009;276:3689–94.
 29. Walkup KR, Shumaker RW, Pruetz JD. Orangutans (Pongo spp.) may 
prefer tools with rigid properties to flimsy tools. J Comp Psychol. 
2010;124:351–5.
 30. Manrique HM, Call J. Spontaneous use of tools as straws in great apes. 
Anim Cognit. 2011;14:213–26.
 31. Mulcahy NJ, Schubiger MN, Suddendorf T. Orangutans (Pongo pygmaeus 
and Pongo abelii) understand connectivity in the skewered grape tool 
task. J Comp Psychol. 2013;127:109–13.
 32. Russon AE, Compost A, Kuncoro P, Ferisa A. Orangutan fish eating, 
primate aquatic fauna eating, and their implications for the origins of 
ancestral hominin fish eating. J Hum Evol. 2014;77:50–63.
 33. Watkins PA, Moser AB, Toomer CB, Steinberg SJ, Moser HW, Karaman 
MW, Ramaswamy K, Siegmund KD, Lee DR, Ely JJ, et al. Identification of 
differences in human and great ape phytanic acid metabolism that could 
influence gene expression profiles and physiological functions. BMC 
Physiol. 2010;10:19.
 34. Antonacci F, Kidd JM, Marques‑Bonet T, Teague B, Ventura M, Girirajan 
S, Alkan C, Campbell CD, Vives L, Malig M, et al. A large and complex 
structural polymorphism at 16p12.1 underlies microdeletion disease risk. 
Nat Genet. 2010;42:745–50.
 35. Prescott SL, Srinivasan R, Marchetto MC, Grishina I, Narvaiza I, Selleri L, 
Gage FH, Swigut T, Wysocka J. Enhancer divergence and cis‑regulatory 
evolution in the human and chimp neural crest. Cell. 2015;163:68–83.
 36. Santostefano KE, Hamazaki T, Biel NM, Jin S, Umezawa A, Terada N. A 
practical guide to induced pluripotent stem cell research using patient 
samples. Lab Invest. 2015;95:4–13.
 37. Wang XM, Yik WY, Zhang P, Lu W, Dranchak PK, Shibata D, Steinberg SJ, 
Hacia JG. The gene expression profiles of induced pluripotent stem cells 
from individuals with childhood cerebral adrenoleukodystrophy are 
consistent with proposed mechanisms of pathogenesis. Stem Cell Res 
Ther. 2012;3:39.
 38. Wang XM, Yik WY, Zhang P, Lu W, Huang N, Kim BR, Shibata D, Zitting 
M, Chow RH, Moser AB, et al. Induced pluripotent stem cell models of 
Zellweger spectrum disorder show impaired peroxisome assembly and 
cell type‑specific lipid abnormalities. Stem Cell Res Ther. 2015;6:158.
 39. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark 
AT, Plath K. Generation of human induced pluripotent stem cells from 
dermal fibroblasts. Proc Natl Acad Sci USA. 2008;105:2883–8.
 40. Toleno DM, Renaud G, Wolfsberg TG, Islam M, Wildman DE, Siegmund 
KD, Hacia JG. Development and evaluation of new mask protocols for 
gene expression profiling in humans and chimpanzees. BMC Bioinform. 
2009;10:77.
 41. Schlaeger TM, Daheron L, Brickler TR, Entwisle S, Chan K, Cianci A, DeVine 
A, Ettenger A, Fitzgerald K, Godfrey M, et al. A comparison of non‑inte‑
grating reprogramming methods. Nat Biotechnol. 2015;33:58–63.
 42. Geijsen N, Horoschak M, Kim K, Gribnau J, Eggan K, Daley GQ. Derivation 
of embryonic germ cells and male gametes from embryonic stem cells. 
Nature. 2004;427:148–54.
 43. Easley CA, Simerly CR, Schatten G. Gamete derivation from embry‑
onic stem cells, induced pluripotent stem cells or somatic cell nuclear 
transfer‑derived embryonic stem cells: state of the art. Reprod Fertil Dev. 
2014;27:89–92.
 44. Hayashi K, Saitou M. Perspectives of germ cell development in vitro in 
mammals. Anim Sci J. 2014;85:617–26.
 45. Imamura M, Hikabe O, Lin ZY, Okano H. Generation of germ cells 
in vitro in the era of induced pluripotent stem cells. Mol Reprod Dev. 
2014;81:2–19.
Page 9 of 9Ramaswamy et al. BMC Res Notes  (2015) 8:577 
 46. Martinez‑Arroyo AM, Medrano JV, Remohi J, Simon C. Germ line develop‑
ment: lessons learned from pluripotent stem cells. Curr Opin Genet Dev. 
2014;28:64–70.
 47. Karaman MW, Houck ML, Chemnick LG, Nagpal S, Chawannakul D, 
Sudano D, Pike BL, Ho VV, Ryder OA, Hacia JG. Comparative analysis of 
gene‑expression patterns in human and African great ape cultured 
fibroblasts. Genome Res. 2003;13:1619–30.
 48. Khaitovich P, Kelso J, Franz H, Visagie J, Giger T, Joerchel S, Petzold E, 
Green RE, Lachmann M, Paabo S. Functionality of intergenic transcription: 
an evolutionary comparison. PLoS Genet. 2006;2:e171.
 49. Khan Z, Ford MJ, Cusanovich DA, Mitrano A, Pritchard JK, Gilad Y. Primate 
transcript and protein expression levels evolve under compensatory 
selection pressures. Science. 2013;342:1100–4.
 50. Zhou X, Cain CE, Myrthil M, Lewellen N, Michelini K, Davenport ER, 
Stephens M, Pritchard JK, Gilad Y. Epigenetic modifications are associated 
with inter‑species gene expression variation in primates. Genome Biol. 
2014;15:547.
 51. Moser AB, Steinberg SJ, Watkins PA, Moser HW, Ramaswamy K, Siegmund 
KD, Lee DR, Ely JJ, Ryder OA, Hacia JG. Human and great ape red blood 
cells differ in plasmalogen levels and composition. Lipids Health Dis. 
2011;10:101.
 52. Moser AB, Hey J, Dranchak PK, Karaman MW, Zhao J, Cox LA, Ryder OA, 
Hacia JG. Diverse captive non‑human primates with phytanic acid‑
deficient diets rich in plant products have substantial phytanic acid levels 
in their red blood cells. Lipids Health Dis. 2013;12:10.
 53. Pai AA, Bell JT, Marioni JC, Pritchard JK, Gilad Y. A genome‑wide study of 
DNA methylation patterns and gene expression levels in multiple human 
and chimpanzee tissues. PLoS Genet. 2011;7:e1001316.
 54. Konopka G, Friedrich T, Davis‑Turak J, Winden K, Oldham MC, Gao F, Chen 
L, Wang GZ, Luo R, Preuss TM, Geschwind DH. Human‑specific transcrip‑
tional networks in the brain. Neuron. 2012;75:601–17.
 55. O’Bleness M, Searles VB, Varki A, Gagneux P, Sikela JM. Evolution of 
genetic and genomic features unique to the human lineage. Nat Rev 
Genet. 2012;13:853–66.
 56. Somel M, Liu X, Khaitovich P. Human brain evolution: transcripts, metabo‑
lites and their regulators. Nat Rev Neurosci. 2013;14:112–27.
 57. Bozek K, Wei Y, Yan Z, Liu X, Xiong J, Sugimoto M, Tomita M, Paabo S, 
Sherwood CC, Hof PR, et al. Organization and evolution of brain lipidome 
revealed by large‑scale analysis of human, chimpanzee, macaque, and 
mouse tissues. Neuron. 2015;85:695–702.
 58. Hrvoj‑Mihic B, Marchetto MC, Gage FH, Semendeferi K, Muotri AR. Novel 
tools, classic techniques: evolutionary studies using primate pluripotent 
stem cells. Biol Psychiatry. 2014;75:929–35.
 59. Hunsberger JG, Efthymiou AG, Malik N, Behl M, Mead IL, Zeng X, Sime‑
onov A, Rao M. Induced pluripotent stem cell models to enable in vitro 
models for screening in the central nervous system. Stem Cells Dev. 
2015;24:1852–64.
 60. Willenbring H, Soto‑Gutierrez A. Transplantable liver organoids made 
from only three ingredients. Cell Stem Cell. 2013;13:139–40.
 61. Chen L, Tang L, Xiang H, Jin L, Li Q, Dong Y, Wang W, Zhang G. Advances 
in genome editing technology and its promising application in evolu‑
tionary and ecological studies. Gigascience. 2014;3:24.
 62. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, Lynch C, Harness 
JV, Lee S, Barrero MJ, et al. Dynamic changes in the copy number of pluri‑
potency and cell proliferation genes in human ESCs and iPSCs during 
reprogramming and time in culture. Cell Stem Cell. 2011;8:106–18.
 63. Wang Y, McClelland M, Xia XQ. Analyzing microarray data using WebArray. 
Cold Spring Harb Protoc. 2009;2009:pdb prot5260.
 64. Xia X, McClelland M, Wang Y. WebArray: an online platform for microarray 
data analysis. BMC Bioinform. 2005;6:306.
 65. Bussey KJ, Chin K, Lababidi S, Reimers M, Reinhold WC, Kuo WL, Gwadry 
F, Ajay, Kouros‑Mehr H, Fridlyand J et al. Integrating data on DNA copy 
number with gene expression levels and drug sensitivities in the NCI‑60 
cell line panel. Mol Cancer Ther. 2006; 5:853–867.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
